Core Viewpoint - The performance of Kangtong Medical has shown a decline in both revenue and net profit, indicating potential challenges in the company's operations and market position [2][3]. Financial Performance - For the period from January to September 2025, Kangtong Medical reported a revenue of 344 million yuan, representing a year-on-year decrease of 30.06% [2]. - The company recorded a net profit attributable to shareholders of -10.21 million yuan, a significant year-on-year decline of 150.92% [2]. Stock Market Activity - On October 29, Kangtong Medical's stock price fell by 1.72%, with a trading volume of 21.42 million yuan [1]. - The financing buy-in amount for Kangtong Medical on the same day was 1.36 million yuan, while the financing repayment was 2.67 million yuan, resulting in a net financing outflow of -1.32 million yuan [1]. - As of October 29, the total margin trading balance for Kangtong Medical was 37.61 million yuan, which accounts for 2.49% of its market capitalization, indicating a low financing balance compared to the past year [1]. Shareholder Information - As of October 20, the number of shareholders for Kangtong Medical was 7,545, a slight decrease of 0.22% from the previous period [2]. - The average number of circulating shares per shareholder increased by 0.23% to 8,355 shares [2]. - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [3]. Institutional Holdings - As of September 30, 2025, the eighth largest circulating shareholder of Kangtong Medical is the Nuoan Multi-Strategy Mixed A fund, which holds 725,100 shares as a new shareholder [3].
港通医疗10月29日获融资买入135.56万元，融资余额3760.46万元